Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,325,071
  • Shares Outstanding, K 48,030
  • Annual Sales, $ 1,858 M
  • Annual Income, $ 123,360 K
  • 36-Month Beta 0.65
  • Price/Sales 3.33
  • Price/Cash Flow 15.75
  • Price/Book 5.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 1.38
  • Number of Estimates 11
  • High Estimate 1.40
  • Low Estimate 1.36
  • Prior Year 1.30
  • Growth Rate Est. (year over year) +6.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.86 +8.96%
on 08/31/18
132.49 -0.60%
on 09/14/18
+10.18 (+8.38%)
since 08/24/18
3-Month
108.88 +20.95%
on 06/28/18
132.49 -0.60%
on 09/14/18
+18.58 (+16.43%)
since 06/25/18
52-Week
96.70 +36.18%
on 02/09/18
132.49 -0.60%
on 09/14/18
+25.85 (+24.42%)
since 09/25/17

Most Recent Stories

More News
Pra Health Scien is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (PRAH , CRL , QGEN , WAT , TMO )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

CRL : 131.69 (+2.28%)
PRAH : 109.17 (+0.67%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (CRL , PRAH , ILMN , A , BRKR )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

ILMN : 359.01 (+0.21%)
CRL : 131.69 (+2.28%)
PRAH : 109.17 (+0.67%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (NEO , CRL , LMNX , BRKR , A )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

LMNX : 30.16 (+1.93%)
NEO : 14.93 (+2.61%)
CRL : 131.69 (+2.28%)
SmarTrend Watching for Potential Pullback in Shares of Charles River La After 2.07% Gain

Charles River La (NYSE:CRL) traded in a range yesterday that spanned from a low of $122.35 to a high of $123.84. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of...

CRL : 131.69 (+2.28%)
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Charles River Laboratories International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty...

CRL : 131.69 (+2.28%)
Charles River Laboratories (CRL) Beats Q2 Earnings and Revenue Estimates

Charles River (CRL) delivered earnings and revenue surprises of 10.96% and 2.77%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

CRL : 131.69 (+2.28%)
Charles River: 2Q Earnings Snapshot

WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported second-quarter profit of $53.7 million.

CRL : 131.69 (+2.28%)
Charles River Laboratories Announces Second-Quarter 2018 Results from Continuing Operations

--- Second-Quarter GAAP Earnings per Share of $1.06 and Non-GAAP Earnings per Share of $1.62 -

CRL : 131.69 (+2.28%)
Charles River La Rises 1.12% on Heavy Volume: Watch For Potential Pullback

Charles River La (NYSE:CRL) traded in a range yesterday that spanned from a low of $127.41 to a high of $129.49. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

CRL : 131.69 (+2.28%)
Can Tenet Healthcare (THC) Keep Earnings Beat Alive in Q2?

Tenet Healthcare (THC) is likely to repeat its success story in Q2 on the back of a strong performance at the Conifer segment as well as its key initiatives.

CRL : 131.69 (+2.28%)
BHC : 24.78 (-0.32%)
THC : 28.07 (-1.78%)
CGC : 52.74 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade CRL with:

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

2nd Resistance Point 133.74
1st Resistance Point 132.72
Last Price 131.69
1st Support Level 129.85
2nd Support Level 128.00

See More

52-Week High 132.49
Last Price 131.69
Fibonacci 61.8% 118.82
Fibonacci 50% 114.60
Fibonacci 38.2% 110.37
52-Week Low 96.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar